Dynamics of PfHRP2 Antigen-Based Diagnostic Tool Efficiencies During High Seasonal Malaria Transmission

Technical Summary: Dynamics of PfHRP2 Antigen-Based Diagnostic Tool Efficiencies During High Seasonal Malaria Transmission

Problem Statement
Accurate malaria diagnosis is critical for effective case management and surveillance, particularly in endemic regions like Nigeria, which bears a significant global burden of the disease. While the World Health Organization (WHO) recommends microscopy as the gold standard, its reliance on skilled personnel and infrastructure limits its utility in rural, resource-limited settings. Antigen-based Rapid Diagnostic Tests (RDTs), specifically those detecting Plasmodium falciparum histidine-rich protein-2 (PfHRP2), have emerged as a cost-effective alternative. However, their diagnostic efficiency is subject to variables such as antigen gene deletions, antigen persistence post-treatment, and product inadequacies. There is a critical need for continuous surveillance of these RDTs during peak transmission seasons to validate their sensitivity, specificity, and predictive values against molecular and microscopic standards.

Methodology
This cross-sectional study was conducted in six districts of Ibadan, Southwest Nigeria, during the peak malaria transmission season (June–September 2024).

• Study Population: 511 participants (aged 6 months to 20 years) presenting with malaria symptoms (fever, fatigue, vomiting, etc.) were enrolled from community health facilities.
• Diagnostic Protocol:
  • Initial Screening: Participants underwent on-field testing using a PfHRP2-based RDT.
  • Laboratory Evaluation: Whole blood samples were collected and subjected to:
    1. Light Microscopy: Thick blood films stained with 10% Giemsa to determine parasite density.
    2. Polymerase Chain Reaction (PCR): A subset of 153 participants was selected for molecular confirmation using conventional PCR targeting the Pfmsp1 (merozoite surface protein 1) gene. Genomic DNA was extracted using a modified Chelex method.
• Statistical Analysis: Diagnostic indices (sensitivity, specificity, PPV, NPV, accuracy) were calculated using PCR as the reference standard. Agreement between methods was assessed using Cohen's kappa coefficient, and discordance was evaluated using the McNemar test.

Key Results

• Prevalence: The on-field prevalence using PfHRP2 RDT was 84.3% (431/511), while microscopy showed 88% (449/511). PCR analysis of the 153-sample subset revealed a positivity rate of 82.35% (126/153).
• RDT Performance vs. PCR:
  • Sensitivity: 92.7% (114/123).
  • Specificity: 3.7% (1/27), indicating a high rate of false positives.
  • Predictive Values: Positive Predictive Value (PPV) was 81.4%; Negative Predictive Value (NPV) was 10.0%.
  • Agreement: Cohen's kappa indicated slight agreement ($\kappa \approx 0.02$).
  • Discordance: Significant discordance was observed ($p < 0.001$), driven largely by RDT-positive/PCR-negative results.
• Microscopy Performance vs. PCR:
  • Sensitivity: 93.7%; Specificity: 29.6%.
  • Agreement: Fair agreement ($\kappa \approx 0.24$).
• RDT vs. Microscopy: High sensitivity (93.3%) but low specificity (6.3%) with slight agreement ($\kappa \approx 0.05$).
• Invalidity: The RDT invalidity rate was low (<2%), suggesting reliable product quality and handling.

Key Contributions

1. Seasonal Validation: The study provides empirical data on the performance of PfHRP2 RDTs specifically during the high-transmission season in a Nigerian endemic setting, revealing a prevalence rate (~75% PCR-corrected) significantly higher than the national annual average.
2. Diagnostic Discrepancy Analysis: It highlights a critical limitation in the specificity of the tested PfHRP2 RDT when compared to PCR. The study identifies that while the RDT is highly sensitive, its low specificity (3.7%) suggests a substantial number of false positives, potentially leading to unwarranted treatment.
3. Antigen Persistence Context: The authors discuss the potential role of PfHRP2 antigen persistence post-parasite clearance as a confounding factor for false positives, noting that the long half-life of the antigen can lead to detection in the absence of active infection.
4. Gene Deletion Assessment: The study found no evidence that PfHRP2/3 gene deletions were responsible for the observed false negatives, as no sample was RDT-negative but positive for both PCR and microscopy.

Significance and Claims
The paper claims that while the PfHRP2-based kit demonstrates measurable strengths in field applicability and high sensitivity, its low specificity relative to PCR reveals key limitations for routine clinical practice. The authors assert that the high rate of false positives may result in unwarranted treatment, while the low NPV indicates that a negative result does not reliably rule out infection in this specific context.

The study concludes that despite these limitations, RDTs remain useful for malaria diagnosis in endemic settings. However, the findings underscore the necessity for continued performance monitoring and rigorous quality assurance to minimize diagnostic errors. The authors do not advocate for an immediate shift to PCR-based approaches or multi-biomarker RDTs as a replacement but emphasize that the current limitations warrant careful consideration in clinical decision-making and surveillance protocols.